NykodeVisit company website
Nykode is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies.
Nykode is a leader in the rapidly developing field of individualized cancer neoantigen vaccines and is using the Nykode technology to generate best-in-class therapeutics to treat cancers with a high unmet medical need. Nykodes front runner program (VB10.16) is a therapeutic DNA vaccine against HPV16 induced pre-malignancies and malignancies.
Foto: Ingar Næss